Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE*3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)*-Reference-Cited by-同舟云学术

Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE*3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)*

Published:2008-09 Issue:9 Volume:36 Page:2576-2582
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

van der Hoorn José W.,Jukema J Wouter,Bekkers Marian E.,Princen Hans M.,Corda Stefano,Emeis Jeff J.,Steendijk Paul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference39 articles.

1. Signalling networks regulating cyclooxygenase-2

2. Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?

3. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

4. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostanoids in Cardiac and Vascular Remodeling;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-03

2. Planning for nodes, places and people in Flanders and Brussels: Developing an empirical railway station assessment model for strategic decision-making;Journal of Transport and Land Use;2019-11-22

3. Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk;Current Medicinal Chemistry;2017-10-25

4. Cardiovascular System;Comparative Pathophysiology and Toxicology of Cyclooxygenases;2012-08-20

5. Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke;Medicinal Research Reviews;2012-03-20